{"transactions":[{"id":2775465,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":140993,"kind":"person","name":"SCHREIBER DAVID","position":1,"cik":"0001255627","reported_name":"SCHREIBER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-23T21:15:17.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":4031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in two equal installments on April 1, 2021 and June 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total reflects the adjustment of 17,528 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020."}],"balance_after":171521,"source":{"system":"sec-edgar","filing":"0001255627-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000125562721000001/primary_doc.xml","form_type":"4"}},{"id":3034787,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":140993,"kind":"person","name":"SCHREIBER DAVID","position":1,"cik":"0001255627","reported_name":"SCHREIBER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-10T21:35:49.000Z","date":"2020-09-08","kind":"sale","acquired":false,"shares":50000,"price":2.78,"value":139000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The proceeds are intended to cover tax liability for restricted stock units of Aspira Women's Health Inc. received in 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale reported in column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $2.75 to $2.85 per share.  The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":185018,"source":{"system":"sec-edgar","filing":"0001255627-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000125562720000002/primary_doc.xml","form_type":"4"}},{"id":3198400,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":140993,"kind":"person","name":"SCHREIBER DAVID","position":1,"cik":"0001255627","reported_name":"SCHREIBER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-23T21:08:19.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":70113,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020."}],"balance_after":235018,"source":{"system":"sec-edgar","filing":"0001255627-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000125562720000001/primary_doc.xml","form_type":"4"}},{"id":3503304,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":140993,"kind":"person","name":"SCHREIBER DAVID","position":1,"cik":"0001255627","reported_name":"SCHREIBER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T23:07:48.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":10000,"price":1.1,"value":11000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":164905,"source":{"system":"sec-edgar","filing":"0001255627-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000125562719000003/primary_doc.xml","form_type":"4"}},{"id":3575839,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":140993,"kind":"person","name":"SCHREIBER DAVID","position":1,"cik":"0001255627","reported_name":"SCHREIBER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-28T22:46:01.000Z","date":"2019-03-26","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019."}],"balance_after":174905,"source":{"system":"sec-edgar","filing":"0001255627-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000125562719000002/primary_doc.xml","form_type":"4"}},{"id":3602908,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":140993,"kind":"person","name":"SCHREIBER DAVID","position":1,"cik":"0001255627","reported_name":"SCHREIBER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-03-11T20:20:12.000Z","date":"2019-03-07","kind":"sale","acquired":false,"shares":30000,"price":1,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":137405,"source":{"system":"sec-edgar","filing":"0001255627-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000125562719000001/primary_doc.xml","form_type":"4"}},{"id":3962561,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":140993,"kind":"person","name":"SCHREIBER DAVID","position":1,"cik":"0001255627","reported_name":"SCHREIBER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-17T20:07:27.000Z","date":"2018-04-13","kind":"grant","acquired":true,"shares":79200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2018, 25% of the restricted stock units will vest on September 1, 2018 and 25% of the restricted stock units will vest on December 1, 2018."}],"balance_after":167405,"source":{"system":"sec-edgar","filing":"0001255627-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000125562718000001/primary_doc.xml","form_type":"4"}},{"id":4371876,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":140993,"kind":"person","name":"SCHREIBER DAVID","position":1,"cik":"0001255627","reported_name":"SCHREIBER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-27T20:56:05.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2017, 25% of the restricted stock units will vest on September 1, 2017 and 25% of the restricted stock units will vest on December 1, 2017."}],"balance_after":88205,"source":{"system":"sec-edgar","filing":"0001255627-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000125562717000001/primary_doc.xml","form_type":"4"}}]}